Management of viral hepatitis in hematologic malignancies.
about
Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impactCancer and liver cirrhosis: implications on prognosis and management2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinomaDifferences in the patterns and outcomes of enhanced viral replication between hepatitis C virus and hepatitis B virus in patients with hepatocellular carcinoma during transarterial chemolipiodolizationHCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy: Evidence and open questions.The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies.Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor.Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation.Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.Patients with hematological malignancies and serological signs of prior resolved hepatitis B.Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy.Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxisAcute exacerbation of hepatitis C in hepatocellular carcinoma patients receiving chemotherapy.Management of HBV infection during immunosuppressive treatmentCoadministration of telaprevir and transcatheter arterial chemoembolization in hepatitis C virus-associated hepatocellular carcinoma.The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy.Perception of hepatitis B virus infection reactivation-related issues among specialists managing hematologic malignancies: result of an Italian survey.Sustained seroconversion of chronic hepatitis B infection after stem cell transplantation.Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease.Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases.Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
P2860
Q22299128-EE8DFB55-F89E-4C17-9734-395E5BB44346Q28068579-EDDE34D5-EF51-4C42-B853-41B9E11B96DDQ28392783-393859EB-1F6C-4216-94C6-0503F87A45A5Q28394414-39ABEDEF-6640-4059-90A4-3B07664D58C7Q35833221-C71469C5-C73F-4191-B681-805229511EFEQ35854495-AED30EA6-7DB8-4471-AA8B-F8265D7EEA35Q36038914-16293AA6-0587-4CF8-8912-F4034D9B32CEQ36654518-67CF8284-75D1-48B9-8056-EFC6E20484F8Q37912229-4A9332EB-36B5-4E76-A6F8-5A7A89B74DE6Q37978202-5C0B46AD-EF23-4150-8468-60947BD9D374Q37999022-4A98C25E-6505-45D5-9FBC-02415799267BQ38062943-8E641099-BB7A-45C9-857A-784653645556Q38094015-D8B8529E-4283-4619-89CD-B1E47E59986DQ39702687-73B3FE61-3847-4ACA-9CE0-6171E5DC018DQ41859437-384E3F75-1C52-4E7C-8DBA-61DD2F650B62Q42101421-107CD740-D4E4-45FB-9783-9E62A4C2124CQ42203535-47E5238A-CBBD-4BE4-8EDE-0DE3C7A4C5ECQ42240548-642FAA85-65AD-4E5A-95EC-9931F05873E6Q43480193-FE5A59C3-C0EE-4517-97F2-ACF92630F113Q45358091-4D524C4E-C23D-4970-B438-9ECBC6DF36E4Q45359644-D4B2B0D5-58BE-4D40-987E-D751387C7CAAQ45367090-CA73031C-66D1-43F6-BC11-0018E63FB681
P2860
Management of viral hepatitis in hematologic malignancies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of viral hepatitis in hematologic malignancies.
@en
Management of viral hepatitis in hematologic malignancies.
@nl
type
label
Management of viral hepatitis in hematologic malignancies.
@en
Management of viral hepatitis in hematologic malignancies.
@nl
prefLabel
Management of viral hepatitis in hematologic malignancies.
@en
Management of viral hepatitis in hematologic malignancies.
@nl
P1433
P1476
Management of viral hepatitis in hematologic malignancies.
@en
P2093
David R Nelson
Roberto J Firpi
P304
P356
10.1016/J.BLRE.2008.02.001
P577
2008-03-14T00:00:00Z